| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 04/16/2002 | US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 04/11/2002 | WO2001085671A3 Anthranyl amides and their use as medicaments |
| 04/11/2002 | WO2001072688A3 Method for preparing (2s,3r,4s)-4-hydroxyisoleucine and analogues thereof |
| 04/11/2002 | US20020042525 Process for producing pyrone compounds |
| 04/11/2002 | US20020042512 Alpha-acyl- and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 04/10/2002 | CN1344264A Tetrahydropyran derivatives and their use as therapeutic agents |
| 04/09/2002 | US6369223 Using catalyst complex |
| 04/09/2002 | US6369100 Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids |
| 04/04/2002 | WO2002026227A1 Lactone integrin antagonists |
| 04/04/2002 | US20020040154 Reacting arylhydroxy compound and an epoxy compound to form an epoxy-aryl ether; reacting epoxy-aryl ether with active methylene compound to form a lactone; reducing to provide hydroxy-substituted tetrahydrofuran |
| 04/04/2002 | CA2423434A1 Lactone integrin antagonists |
| 04/03/2002 | EP1193263A1 Process for producing pyrone compounds |
| 04/03/2002 | EP1192122A1 Benzene derivatives, preparation method and pharmaceutical compositions containing same |
| 04/03/2002 | EP1095653A9 Glucopyranose derivatives and preventives and/or remedies for hiv infection containing the same as the active ingredient |
| 04/03/2002 | EP1024695A4 Fungicide comprising 4-methyl-6-pentyl-2h-pyran-2-one |
| 04/03/2002 | CN1343211A Phosphabenzene compounds and theie use as ligands for hydroformylation catalysts |
| 04/03/2002 | CN1343205A Dimeric compounds and as inhibitors of neuraminidase |
| 03/28/2002 | WO2002024675A1 Process for manufacturing simvastatin and the novel intermediates |
| 03/28/2002 | WO2002024632A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
| 03/28/2002 | WO2002024194A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 03/28/2002 | WO2001097751A3 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
| 03/28/2002 | WO2001045484A3 An improved process for preparing simvastatin |
| 03/28/2002 | US20020038037 Processes for preparing 3-arylsulfur hydroxamic acids |
| 03/28/2002 | US20020037865 Crystal structure |
| 03/28/2002 | CA2422820A1 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 03/27/2002 | CN1341595A Nonviscous protein type synthetic compound or its carrier combined compound |
| 03/26/2002 | CA2041588C Cyclohexenone oxime ethers, their preparation, intermediates for their preparation and their use as herbicides |
| 03/21/2002 | WO2002022694A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 03/21/2002 | WO2002022618A1 Method for preparing camptothecin and its derivatives |
| 03/21/2002 | WO2002022556A1 Novel amide derivatives and medicinal use thereof ugs |
| 03/21/2002 | WO2001040212A3 Pyrone derivatives and a method for producing same |
| 03/21/2002 | US20020035274 Process for producing simvastatin and/or its derivatives |
| 03/21/2002 | US20020035132 Tetrahydropyran derivatives and their use as therapeutic agents |
| 03/21/2002 | US20020035055 Cyclic acetal that forms fragrant ketone and fragrant lactone; perfumes |
| 03/21/2002 | US20020034797 Modified modular pks with retained scaffold |
| 03/21/2002 | US20020033472 Difluorovinyl compound, liquid crystal composition and liquid crystal display |
| 03/21/2002 | DE10138935A1 Synthetische Verbindungen vom Nicht-Mucintyp oder ihre mit einem Träger konjugierten Verbindungen Synthetic compounds from non-mucin or its conjugated with a carrier compounds |
| 03/21/2002 | CA2421054A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 03/20/2002 | EP1188439A2 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
| 03/19/2002 | US6359151 Use as pesticides. |
| 03/19/2002 | US6359147 Reactions catalyzed by chromium (III) carboxylates |
| 03/19/2002 | US6358980 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection |
| 03/19/2002 | US6358960 For therapy of intravascular coagulation, coronary thrombosis, cerebral infarction, cerebral embolism, transient ischemic attack, cerebrovascular disorders, pulmonary vascular diseases, deep venous thrombosis, etc. |
| 03/14/2002 | WO2002020514A1 Multivalent neuraminidase inhibitor conjugates |
| 03/14/2002 | WO2002020500A2 Materials and methods to potentiate cancer treatment |
| 03/14/2002 | WO2002020485A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/14/2002 | WO2002020457A1 Dihydroxy open-acid salt of simvastatin |
| 03/14/2002 | US20020032186 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 03/14/2002 | US20020032158 Having anti-tumor activity and immunostimulating activity |
| 03/14/2002 | US20020030179 Having negative and large dielectric anisotropy value and small optical anisotropy value at the same time |
| 03/14/2002 | DE10041402A1 Neue Verbindungen, die Faktor Xa-Aktivität inhibieren Novel compounds which inhibit factor Xa activity |
| 03/14/2002 | CA2421018A1 Dihydroxy open-acid salt of simvastatin |
| 03/14/2002 | CA2417177A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/14/2002 | CA2416336A1 Multivalent neuraminidase inhibitor conjugates |
| 03/13/2002 | EP1186600A1 Process for the preparation of substituted pyranes |
| 03/13/2002 | EP1185518A1 Alpha-phenyl-beta-ketosulfone |
| 03/13/2002 | EP1071640B1 Asymmetric synthesis of 2-aryl-1-substituted butan-2,3-diols |
| 03/12/2002 | US6355806 Regulators of cell proliferation and differentiation, agents for treating skin-related diseases |
| 03/12/2002 | US6355674 Psychological disorders; antiserotonine agents |
| 03/07/2002 | WO2002018327A2 Guanidinobenzamides as mc4-r agonists |
| 03/07/2002 | US20020028955 Chirality conversion method in lactone sugar compounds |
| 03/07/2002 | US20020028954 Useful as biodegradable surfactants and in enzymatic processes using a chitinase (N-acetylglucosaminidase) |
| 03/07/2002 | US20020028774 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/06/2002 | EP1183261A1 Method for separating analogous organic compounds |
| 03/06/2002 | EP1183239A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/06/2002 | CN1338452A Substituted phenylamine derivatives |
| 03/06/2002 | CA2356582A1 Process for the preparation of substituted pyranes |
| 03/05/2002 | CA2098277C Preparation of formyltetrahydropyrans |
| 02/28/2002 | WO2002016344A1 Tetrahydropyran derivatives as nk-1 receptor antagonists |
| 02/28/2002 | WO2002016343A1 Tetrahydropyran derivatives as nk-1 receptor antagonists |
| 02/28/2002 | WO2002015894A2 Use of vitamin d derivatives as bone resorption inhibitors |
| 02/28/2002 | WO2001064663A3 Biologically active analogs of discodermolide |
| 02/28/2002 | CA2420274A1 Use of vitamin d derivatives as bone resorption inhibitors |
| 02/27/2002 | EP1182195A1 Cyclic compounds and uses thereof |
| 02/27/2002 | EP1182186A2 Difluoromethyl ether derivative and process for producing the same |
| 02/27/2002 | EP1181286A1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 02/27/2002 | CN1337948A Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (MMP) inhibitors/TNF-alpha converting enzyme (TACE) inhibitors |
| 02/27/2002 | CN1337946A S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 02/27/2002 | CN1337945A Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 02/27/2002 | CN1079798C 3-aryl-tetronic acid derivatives, the production thereof and the use thereof as antiparasitic agents, and the intermediate |
| 02/26/2002 | US6350761 Benzenamine derivatives as anti-coagulants |
| 02/21/2002 | WO2002014300A1 Processes for the production of pyrone compounds |
| 02/21/2002 | WO2002014267A1 Novel aminocyclohexane derivatives |
| 02/21/2002 | US20020022604 4-oxo-4h-pyran derviatives; use as inhibitors of serine proteases; anticoagulants; treating thrombotic conditions including coronary artery and cerebrovascular diseases |
| 02/21/2002 | US20020022575 Dialkyl-halogenophenyl-substituted ketoenols |
| 02/21/2002 | DE10134299A1 New stable mesogenic tetrafluoroethylene-bridged dioxane derivatives, useful in liquid crystal displays, especially of the TFT or STN type |
| 02/21/2002 | DE10040051A1 Derivate des 4-(Trifluormethyl)-phenols sowie Derivate des 4-(Trifluormethylphenyl)-2-(tetrahydropyranyl)ethers und Verfahren zu ihre Herstellung Derivatives of 4- (trifluoromethyl) phenol and derivatives of the 4- (trifluoromethylphenyl) -2- (tetrahydropyranyl) ethers and processes for their preparation |
| 02/20/2002 | EP1180514A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same |
| 02/20/2002 | CN1336907A Process for the production of alkanediol derivatives |
| 02/19/2002 | US6348244 Liquid-crystal compounds having large negative value of permittivity anisotropy, liquid-crystal composition, and liquid-crystal display element |
| 02/14/2002 | WO2002012534A2 Bio-intermediates for use in the chemical synthesis of polyketides |
| 02/14/2002 | WO2002012220A2 Process for preparing discodermolide and analogues thereof |
| 02/14/2002 | WO2002012219A1 Method for producing 3,4-dihydro-2h-pyran |
| 02/14/2002 | WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials |
| 02/14/2002 | WO2001042408A3 Ether-capped poly(oxyalkylated) alcohol surfactants |
| 02/14/2002 | US20020019534 Gem substituted hydroxamic acids |
| 02/14/2002 | US20020019382 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 02/14/2002 | DE10037786C1 Verfahren zur Herstellung von 3,4-Dihydro-2H-pyran A process for the preparation of 3,4-dihydro-2H-pyran |
| 02/14/2002 | CA2417358A1 Bio-intermediates for use in the chemical synthesis of polyketides |
| 02/13/2002 | EP1178986A2 Furanone derivatives as inhibitors of cathepsin s |